Search results
Why Is Editas (EDIT) Down 21% Since Last Earnings Report?
Zacks via Yahoo Finance UK· 1 year agoA month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have lost...
U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead
Reuters via Yahoo Finance UK· 2 years agoWASHINGTON (Reuters) -The U.S. Supreme Court on Monday rebuffed a bid by Bristol Myers Squibb Co's...
Editas (EDIT) Q1 Earnings Top, Pipeline in Focus, Stock Up
Zacks via Yahoo Finance UK· 1 year agoEditas Medicine (EDIT) stock climbs 12% on Friday and 7% in the pre-market hours today, after the...
Editas (EDIT) Q4 Earnings Miss Estimates, Pipeline in Focus
Zacks via Yahoo Finance UK· 1 year agoEditas (EDIT) reports a wider loss in the fourth quarter of 2022. The strategic reprioritization,...